Sign inJoin waitlistJoin the waitlist

Tian Zhang

Associate Director of Clinical Research · Simmons Comprehensive Cancer Center

Credentials: · · · ·

History

UT Southwestern Medical Center
Present

Duke University Medical Center
2012–2015
Duke University Medical Center
2009–2012
Duke University
2009–2010
Harvard Medical School
2005–2009

Research

Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy
Nature Nanotechnology · 2017 · 527 citations
Combination strategies to maximize the benefits of cancer immunotherapy
Review · Journal of Hematology & Oncology · 2021 · Co-first of 8 authors · 519 citations
miR-137 regulates ferroptosis by targeting glutamine transporter SLC1A5 in melanoma
Cell Death and Differentiation · 2018 · 402 citations

Daniel George
65 papers
Andrew Armstrong
45 papers
Andrew Wang
28 papers
Michael Harrison
26 papers
Hans Hammers
13 papers
Qian Qin
12 papers
Rana McKay
12 papers · 5 as a resident
Sumanta Pal
12 papers
Landon Brown
11 papers · 11 as a fellow
Rajan Gupta
11 papers
Brian Rini
10 papers
CK
Chester Kao
10 papers · 10 as a resident

Clinical trials

Sequential Treatment of Cabozantinib for Advanced Renal Cell Carcinoma (RCC)
Principal investigator · Recruiting · Phase 2
University of Texas Southwestern Medical Center
2023–2028
TRIO Bladder: A Study of Durvalumab Plus Tremelimumab Followed by Concurrent Durvalumab Plus Bladder Radiation in Muscle-Invasive Bladder Cancer
Principal investigator · Withdrawn · Phase 1
Daniel George, MD
2020–2026
A Salvage Trial of AR Inhibition With ADT and Apalutamide With Radiation Therapy Followed by Docetaxel in Men With PSA Recurrent Prostate Cancer After Radical Prostatectomy (STARTAR)
Principal investigator · Completed · Phase 2
Andrew J. Armstrong, MD
2018–2022